Infinium Global Research Cephalosporin Drugs Market | Page 9

Global Cephalosporin Drugs Market Trend Analysis and Forecast to 2023
EXECUTIVE SUMMARY
GLOBAL CEPHALOSPORIN DRUGSMARKET HIGHLIGHTS, (USD BILLION)
The Cephalosporin are medicine that kill bacteriaor prevent their growth.
Cephalosporin drugs are a newer class of antibiotics and often are seen as an
alternative to penicillin for many patients. Moreover, clinical studies are ongoing
for comparing this class of antibiotics to penicillin in combating various infections.
Cephalosporin drugs are used to treat infections in different parts of the body such
as ears, nose, throat, lungs, sinuses, and skin. Physicians also prescribe these drugs
to treat pneumonia, strep throat, staph infections, tonsillitis, bronchitis, and
gonorrhea. Hence multiple benefits associated with cephalosporin drugs are likely
to boost the size of global cephalosporin drugs market in the near future.In 2014,
size of the global Cephalosporin drugs market was valued USD XXX million and it is
expected to grow with a CAGR of X.X% over the period of 2016 to 2022 and reach
USD XXX million by 2022.
Rising prevalence of infectious diseases, increasing awareness among patients,
multiple treatment options and special regulatory designation for pipeline
molecules are considered to be prime factors driving the growth of cephalosporin
market. Stringent government policies, low investment in R&D activities and high
generic penetration of these drugs are the key restraining factors for the growth of
the market. Moreover, use of combination therapies for treatment, development
of highly efficient and safe cephalosporin drugs, and increasing incidence of
mergers and acquisition are anticipated to bring more opportunities for the growth
of this market. Furthermore, resistance by government on drug development and
weak pipeline molecules are some of the primary challenges faced by the global
Cephalosporin drugs market.
Some of the key players in the Global Cephalosporin Drugsmarket are Allergan,
Astellas,Bristol-Myers Squibb, GSK, Merck, Abbott, Aspen Pharmacare,
AstraZeneca, Johnson & Johnson, Sun Pharmaceutical, Orchid Pharma,
TheravanceBiopharma,
Pfizer,
Baxter,
Basilea
Pharmaceuticals,
InceptaPharmacueticals, Sandoz and others.
9
|
©Infinium Global Research